Panbela Therapeutics, Inc.
PBLADelisted Apr 25, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001029125
Panbela Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 19, 2024; 11 institutions reported holding it in 13F filings for Q4 2023, worth $115.8K in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Panbela Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −2 vs. Q3 2022
- Shares held
- 483.9K
- −2.49M (−83.7%) vs. Q3 2022
- Total value
- $34.5K
- −$766.5K (−95.7%) vs. Q3 2022
- New holders
- 3
- 2 more added
- Sold out
- 5
- 4 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 11 | $115.8K |
| Q3 2023 | 7 | $71.8K |
| Q2 2023 | 9 | $945.1K |
| Q1 2023 | 20 | $857.7K |
| Q4 2022 | 15 | $34.5K |
| Q3 2022 | 17 | $801.0K |
| Q2 2022 | 13 | $111.0K |
| Q1 2022 | 16 | $1.78M |
| Q4 2021 | 17 | $1.72M |
| Q3 2021 | 18 | $2.41M |
| Q2 2021 | 17 | $3.12M |
| Q1 2021 | 15 | $2.74M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Panbela Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 213,498 | $14.9K | 0.00% | +23,005+12.1% | Added |
| Two Sigma Securities, LLC | 66,165 | $4.85K | 0.00% | +66,165 | New |
| Renaissance Technologies LLC | 54,541 | $4.00K | 0.00% | +54,541 | New |
| Morgan Stanley | 32,500 | $2.38K | 0.00% | −11,836−26.7% | Reduced |
| Cetera Advisor Networks LLC | 22,659 | $1.66K | 0.00% | +22,659 | New |
| Vanguard Group Inc | 20,608 | $1.51K | 0.00% | −201,695−90.7% | Reduced |
| Oxford Financial Group Ltd | 20,000 | $1.47K | 0.00% | 00.0% | Unchanged |
| Verition Fund Management LLC | 20,000 | $1.46K | 0.00% | −10.0% | Reduced |
| Tower Research Capital LLC (TRC) | 12,622 | $1.00K | 0.00% | −471−3.6% | Reduced |
| Geode Capital Management, LLC | 13,958 | $1.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,857 | $209 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 633 | $46 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 201 | $15 | 0.00% | +73+57.0% | Added |
| Advisor Group Holdings, Inc. | 3,115 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −2,176,809−100.0% | Sold out |
| Clear Street LLC | 0 | $0 | 0.00% | −110,500−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −71,759−100.0% | Sold out |
| Brand Asset Management Group, Inc. | 0 | $0 | 0.00% | −57,144−100.0% | Sold out |
| Buckingham Strategic Wealth, LLC | 0 | $0 | 0.00% | −24,927−100.0% | Sold out |